Trials / Completed
CompletedNCT03578302
The Heidelberg Engineering BI US Evaluation Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Heidelberg Engineering GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Evaluation of defined parameters measured in pathological and non-pathological eyes with the Heidelberg BI
Detailed description
The primary objectives of this study are to assess the feasibility to acquire acceptable images and to assess repeatability
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BI Anterior Segment Mode | Single eye measurement in Anterior Segment Mode |
| DEVICE | BI Anterior Segment and IOL Biometry Mode | Eye measurement 3 times with and without dilation in IOL biometry and Anterior Segment mode |
Timeline
- Start date
- 2018-05-22
- Primary completion
- 2018-12-03
- Completion
- 2018-12-03
- First posted
- 2018-07-06
- Last updated
- 2025-06-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03578302. Inclusion in this directory is not an endorsement.